Saturday 17 October 2026 Export PHAR’s income statement to Excel — free account

Pharming Group N.V. Sponsored ADR

Pharming Group N.V. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $376.1 million, up 26.6% from fiscal 2024. In the quarter to June 2026, revenue fell 3.22%, EPS fell 57.1%, free cash flow fell 183.9% and total debt rose 1.55%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

9.36 0.27 −2.80%

Follow PHAR

Alert me

Market cap: $681.6M
P/E: 62.4×
Fwd P/E: 0.0×
Dividend yield: —
F-score: 5/9
Altman Z: 3.88
Beneish M: −2.78
Dividend safety: n/a

Overview Business Profile Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	92.60	87.58	441.75	1,450.00	+8 more quarters Free account
P/S ratio Full definition →	2.02	3.35	3.24	2.73
P/FCF ratio Full definition →	21.56	22.24	22.56	18.76
P/Operating CF Full definition →	(76.70)	634.83	113.67	30.87
P/B ratio Full definition →	2.74	4.61	4.39	3.74
Price to Tangible BV Full definition →	5.20	8.98	8.60	7.62
EV/Sales Full definition →	1.86	3.16	3.02	2.54
EV/EBITDA Full definition →	22.26	29.38	30.63	21.93
EV/Operating CF Full definition →	19.42	20.68	20.75	17.25
EV/FCF Full definition →	19.80	20.95	21.04	17.46
Quick Ratio Full definition →	2.31	2.06	2.03	2.39
Current Ratio Full definition →	3.01	2.63	2.59	3.16
Net Debt/EBITDA Full definition →	(13.93)	40.19	(8.62)	(3.70)
Debt/Assets Full definition →	20.91%	20.18%	19.61%	20.76%
Debt/Equity Full definition →	0.36	0.37	0.35	0.37
Asset Turnover Full definition →	0.80	0.83	0.84	0.81
Operating CF/Net income Full definition →	(6.04)	(0.37)	1.96	4.27
Capex/Depreciation Full definition →	(0.03)	(0.08)	(0.08)	(0.03)
Research and Development Expense of Revenue Full definition →	35.81%	35.28%	30.15%	24.05%
Selling, General and Administrative Expense of Revenue Full definition →	48.23%	62.85%	48.15%	52.52%
Intangible Assets out of Total Assets Full definition →	0.27	0.27	0.27	0.28
Share Based Compensation of Revenue Full definition →	3.71%	4.45%	4.23%	3.29%
Graham Net Nets Full definition →	0.11	0.06	0.06	0.07
Graham Number Full definition →	4.14	3.93	1.90	0.93
Earnings Yield Full definition →	1.08%	1.14%	0.23%	0.07%
Free Cash Flow Yield Full definition →	4.64%	4.50%	4.43%	5.33%
Revenue per Share Full definition →	1.69	0.97	1.55	1.43
Operating CF per Share Full definition →	(0.18)	0.03	0.16	0.47
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	(0.18)	0.02	0.15	0.47
Cash per Share Full definition →	2.97	2.29	2.61	2.45
Shareholders Equity per Share Full definition →	5.07	3.61	4.02	3.88
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	5.07	3.61	4.02	3.88
Free Cash Flow Full definition →	(9.74)	1.71	10.44	31.96
Working Capital Full definition →	187.44	183.17	183.68	189.69
Capital Expenditures Full definition →	(0.08)	(0.24)	(0.27)	(0.07)
Net Current Asset Value Full definition →	83.20	75.11	76.61	68.46
EV/EBIT Full definition →	36.83	41.72	43.93	35.06
Capex to Sales Full definition →	0.00	0.00	0.00	0.00
Price to Operating Income Full definition →	40.10	44.30	47.10	37.67
Other line items
Average Receivables Full definition →	55.15	53.76	54.76	45.90
Average Payables Full definition →	80.35	86.14	86.26	75.43
Average Inventory Full definition →	64.57	61.96	60.31	64.68
Average Assets Full definition →	457.12	446.27	449.97	449.65
Average Common Equity Full definition →	255.02	242.13	249.08	245.22

Fold the line items

Columns are period end dates

Stockrow Weekly